Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme

Abstract

Glioblastoma multiforme (GBM), a malignant astrocytic tumour, represents the most frequent tumour of the human brain. Nevertheless, its molecular pathology is not well understood. We utilized the immune system, which contributes to cancer protection, to help identify new GBM-related genes. By screening a human GBM cDNA library with autologous patient serum (SEREX-approach), we isolated a gene termed PHF3 (PHD finger protein 3). The gene product of PHF3 is immunogenic in GBM as tested in an allogenic patient serum screening demonstrating antibodies in 24 of 39 (61.53%) sera, whereas none of the 14 healthy persons had antibodies against PHF3. While previous SEREX studies revealed allogenic antibody responses up to 40%, our results for PHF3 represent the highest reported rate for a specific antibody response. We show that GBM patients with an antibody response against PHF3 show significant better survival than patients without PHF3-specific antibodies. Because the amino acid sequence of PHF3 contains a PHD finger (also termed LAP motif), a TFIIS homology, a proline rich region and nuclear localization signals, it supposedly functions as a transcription factor. A polyclonal antibody generated against PHF3 shows nuclear expression in most investigated formalin-fixed, paraffin embedded tissues. In GBM, PHF3 expression is concentrated in cells surrounding necroses.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aasland R, Gibbons TJ, Stewart AF . 1995 Trend. Biochem. Sci. 20: 56–59

  • Biernat W, Tohma Y, Yonekawa Y, Kleihues P, Ohgaki H . 1997 Acta Neuropathol. 94: 303–309

  • Blaes F, Klotz M, Huwer H, Straub U, Kalweit G, Schimrigk K, Schafers HJ . 2000 Ann. Thorac. Surg. 69: 254–258

  • Boon T, van der Bruggen P . 1996 J. Exp. Med. 183: 725–729

  • Coulson M, Robert S, Eyre HJ, Saint R . 1998 Genomics 48: 381–383

  • Chinot O, Martin PM . 1996 Biologie des tumeurs cérébrales gliales. Artem et Editions espaces 34, Montpellier

  • Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P . 1988 Cancer 62: 2152–2165

  • Dietrich P-Y, Walker PR, Saas P, de Tribolet N . 1997 Ann. NY Acad. Sci. 17: 124–140

  • Foley EJ . 1953 Cancer Res. 13: 835–837

  • Gibbons RJ, Picketts DJ, Villard L, Higgs DR . 1995 Cell 80: 837–845

  • Gilboa E . 1999 Immunity, Sept 260–270

  • Güre AO, Stockert E, Scanlan MJ, Keresztes RS, Jäger D, Altorki NK, Old LJ, Chen YT . 2000 Proc. Natl. Acad. Sci. 11: 4198–4203

  • Hampton TA, Conry RM, Khazaeli MB, Shaw DR, Curiel DT, LoBuglio AF, Strong TV . 2000 Cancer Gene Ther. 7: 446–455

  • Harlow E, Lane D . 1998 Antibodies. A Laboratory Manual Cold Spring Harbour Laboratory: USA

  • Hasenpusch-Theil K, Chadwick BP, Heath SK, Wilkinson DG, Feischauf AM . 1999 Mamm. Genome 10: 294–298

  • Heckel D, Brass N, Fischer U, Blin N, Steudel I, Fackler O, Zang KD, Meese E . 1997 Hum. Mol. Genet. 6: 2031–2041

  • Jung V, Romeike BFM, Henn W, Feiden W, Moringlane JR, Zang KD, Urbschat S . 1999 J. Neuropath. Exp. Neurol. 58: 993–999

  • Kleihues P, Burger PC . 2000 Glioblastoma. In: Tumours of the Nervous System IARC Press: Lyon pp. 29–39

  • Kornblith PL, Coakham HB, Pollock LA, Wood WC, Green SB, Smith BH . 1983 Cancer 52: 2230–2235

  • Merrifield RB . 1963 J. Am. Chem. Soc. 85: 2149–2158

  • Old LJ . 1981 Cancer Res. 41: 361–375

  • Prehn RT, Main JM . 1957 J. Natl. Cancer Inst. 18: 769–778

  • Rainov NG, Doberstein K-U, Fittkau M, Bahn H, Holzhausen HJ, Gantchev I, Burkert W . 1995 Clin. Cancer Res. 1: 775–781

  • Robinson C, Callow M, Stevenson S, Scott B, Robinson BWS, Lake RA . 2000 Am. J. Respir. Cell Mol. Biol. 22: 550–556

  • Saha V, Chaplin T, Gregorini A, Ayton P, Young BD . 1995 Proc. Natl. Acad. Sci. 92: 9737–9741

  • Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M . 1995 Proc. Natl. Acad. Sci. USA 92: 11810–11813

  • Scanlan MJ, Gordan JD, Willaimson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jäger D, Jäger E, Knuth A, Chen YT, Old LJ . 1999 Int. J. Cancer 83: 456–464

  • Scarcella DL, Chow CW, Gonzales MF, Economou C, Brassew F, Ashley DM . 1999 Clin. Cancer Res. 5: 335–341

  • Schlichtholz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calvo F, Soussi T . 1992 Cancer Res. 52: 6380–6384

  • Shrikant P, Benveniste EN . 1996 J. Immunol. 157: 1819–1822

  • Soussi T . 2000 Cancer Res. 60: 1777–1788

  • Suresh MZ . 1996 Anticancer Res. 16: 2273–2278

  • Tureci O, Sahin U, Pfreundschuh M . 1997 Mol. Med. Today 3: 342–349

  • Van den Bruggen P, Traversari C, Chomez P, Chomez P, Lurquin C, de Plaen E, van den Eyde B, Knuth A, Boon T . 1991 Science 254: 1643–1647

  • Weller RO, Kida S, Zhang ET . 1992 Brain Pathol. 2: 277–284

  • Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kündig T, Hengartner H . 1997 Immunol. Rev. 156: 199–209

  • Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosenthal A, Schäfer R . 2000 Nature Genet. 24: 144–152

Download references

Acknowledgements

We thank B Glass and G Bleymehl for critical reading this article. This work was kindly supported by a grant from the Deutsche Forschungsgemeinschaft, SFB 399 project A1. A-K Struss was a recipient of a grant from the Graduiertenkolleg ‘Zelluläre Regulation und Wachstum', Deutsche Forschungsgemeinschaft.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Meese.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Struss, AK., Romeike, B., Munnia, A. et al. PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme. Oncogene 20, 4107–4114 (2001). https://doi.org/10.1038/sj.onc.1204552

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204552

Keywords

This article is cited by

Search

Quick links